COVID-19 public health crisis has resulted in the creation of an "ecosystem" of innovation in India, Biocon chief Kiran Mazumdar-Shaw has said ahead of the annual India-US bio-pharma summit in Boston next week.Mazumdar-Shaw, 68, is one of the key speakers at the 15th edition of the annual virtual summit on June 22 hosted by the USA India Chambers of Commerce.
The other star-studded speakers include Dr Albert Bourla, Chairman and CEO of Pfizer; Dr Francis Collins, Director, National Institutes of Health; Dr Janet Woodcock, Acting Commissioner, US Food and Drug Administration; and Amitabh Kant, CEO of NITI Aayog."The whole intent (of the more than a decade old annual India-US bio pharma summit) is to catalyse an innovation ecosystem in India..